• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

IVX:AU

0.0830 AUD 0.0010 1.19%

As of 01:52:00 ET on 08/28/2014.

Snapshot for Invion Ltd (IVX)

Open: 0.0830 Day's Range: 0.0820 - 0.0840 Volume: 693,095
Previous Close: 0.0840 52wk Range: 0.0530 - 0.1397 1-Yr Rtn: +10.93%

Stock Chart for IVX

No chart data available.
  • IVX:AU 0.0830
  • 1D
  • 1M
  • 1Y
0.0840
Interactive IVX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IVX

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0140
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 44.92
Shares Outstanding (M) 541.23
30 Day Average Volume 725,395
Price/Book (mrq) 3.4658
Price/Sale (ttm) 195.6314
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IVX

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for IVX

Invion Limited develops pharmaceutical products for the treatment of asthma and smoking cessation. The Company also is involved in the treatment autoimmune and inflammatory diseases, such as rheumatoid arthritis.

Gregory CollierCEO/Managing DirectorTom CooganChief Financial Officer
Mitchell GlassVP:R&D/Chief Medical OfficerJames CampbellExecutive Director
More Company Profile & Key Executives for IVX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil